Orkla ASA (ORKLY)

OTCMKTS · Delayed Price · Currency is USD
12.07
+0.10 (0.84%)
May 12, 2026, 3:37 PM EST
Market Cap11.69B +1.7%
Revenue (ttm)7.10B +3.3%
Net Income1.14B +89.4%
EPS1.14 +89.4%
Shares Outn/a
PE Ratio10.28
Forward PE16.77
Dividend0.46 (3.83%)
Ex-Dividend DateApr 27, 2026
Volume9,144
Average Volume50,591
Open12.05
Previous Close11.97
Day's Range12.05 - 12.07
52-Week Range9.91 - 13.90
Beta0.22
RSI38.52
Earnings DateMay 20, 2026

About Orkla ASA

Orkla ASA operates as an industrial investment company within brands and consumer-oriented businesses worldwide. It offers decorative paints, marine coatings, protective coatings, and powder coatings; frozen pizza, condiments, bread toppings, and ready-to-eat meals; bakery, ice cream, and plant-based products; and confectionery, biscuits, and salty snacks. The company also provides branded consumer health products, such as daily nutrition and oral health, wound care, and functional personal care under the Möller’s, Jordan, and Salvequick brand ... [Read more]

Founded 1654
Employees 18,616
Stock Exchange OTCMKTS
Ticker Symbol ORKLY

Financial Performance

In 2025, Orkla ASA's revenue was 71.55 billion, an increase of 3.31% compared to the previous year's 69.25 billion. Earnings were 11.47 billion, an increase of 89.42%.

Financial numbers in NOK Financial Statements

News

Orkla ASA Q1 Profit Down, Interest Income Rises

(RTTNews) - Orkla ASA (ORKLY.PK), a Norwegian industrial investment company,reported Monday lower profit in its first quarter, despite growth in interest income.

2 days ago - Nasdaq

Orkla ASA Transcript: AGM 2026

The AGM reviewed strong 2025 financial results, approved a NOK 6 per share dividend, and passed all board proposals, including capital reduction and auditor change. Strategic focus remains on growth, portfolio simplification, and sustainability, with new board members elected and a shareholder proposal on plastic waste rejected.

20 days ago - Transcripts

Orkla ASA Earnings Call Transcript: Q4 2025

Q4 saw 4.5% organic growth and 17% EBIT adjusted increase, with all major segments except Foods contributing positively. Jotun and Orkla Snacks delivered strong profit growth, while inflation and competitive pressures remain key risks.

3 months ago - Transcripts

Orkla ASA Earnings Call Transcript: Q3 2025

Q3 saw 4.4% organic growth, 9% EPS increase, and NOK 17.9B revenue. Portfolio companies showed mixed performance, with Jotun and Orkla India as key contributors. A NOK 4B share buyback was announced, and raw material costs are expected to stabilize in 2025.

6 months ago - Transcripts

Orkla ASA Earnings Call Transcript: Q2 2025

Organic growth reached 3.8% with strong performance in Fuel Ingredients and Home & Personal Care, while Health and Snacks faced margin pressures from high input costs. Portfolio simplification and a potential India IPO progressed, with EBIT margin and return on capital employed both improving.

10 months ago - Transcripts

Orkla ASA Transcript: Capital Markets Update 2025

Delivered strong TSR and financial improvements, reduced portfolio complexity, and advanced strategic priorities for organic growth, simplification, and targeted M&A. Portfolio companies are on track for 2026 targets, with operational enhancements and ESG progress supporting long-term value creation.

1 year ago - Transcripts

Orkla ASA Earnings Call Transcript: Q1 2025

Solid quarterly results with 2% revenue growth, 10% EBIT (adjusted) increase, and 19% higher EPS year-over-year. Margin improvements were broad-based, though snacks and foods faced volume declines due to high cocoa prices and inventory adjustments. Portfolio simplification and cost-saving initiatives continued.

1 year ago - Transcripts

Orkla ASA Earnings Call Transcript: Q4 2024

Strong EBIT and cash flow growth in 2024, driven by portfolio simplification, margin improvements, and stable market shares. Cocoa price volatility and asset sales shaped the quarter, with a proposed NOK 10 per share dividend reflecting robust performance.

1 year ago - Transcripts

Orkla ASA Earnings Call Transcript: Q3 2024

Q3 delivered strong profit and margin growth, with adjusted EPS up 10% and EBIT up 17% year-over-year. Organic growth was broad-based, cash flow improved, and key segments like Jotun and Orkla Health outperformed, despite inflation and cocoa price pressures.

1 year ago - Transcripts

Orkla ASA Earnings Call Transcript: Q2 2024

Q2 saw 7% EPS growth and 13% EBIT Adjusted growth, with strong margin expansion and positive volume trends across most segments. Portfolio simplification advanced with asset sales, while input costs and private label competition remain key watchpoints.

1 year ago - Transcripts

Orkla ASA Transcript: CMD 2023

2 years ago - Transcripts

Orkla ASA Transcript: Investor Update

3 years ago - Transcripts

Orkla ASA Transcript: AGM 2023

3 years ago - Transcripts

Orkla ASA Transcript: Status Update

4 years ago - Transcripts

Orkla ASA Transcript: CMD 2021

4 years ago - Transcripts